U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 239 results

Status:
US Approved Rx (2017)
First approved in 2017

Class (Stereo):
CHEMICAL (ACHIRAL)



Abemaciclib, previously known as LY2835219, is a potent and selective inhibitor of cyclin-dependent kinases: CDK4 and CDK6, developed by Eli Lilly, which is in clinical trial phase III for the treatment of breast cancer and non-small cell lung cancer...
Status:
US Approved Rx (2021)
First approved in 2014

Class (Stereo):
CHEMICAL (ABSOLUTE)



Oritavancin is an glycopeptide antibiotic with bactericidal activity effective in treating infections caused by Gram-positive organisms. It treats complicated skin and skin structure infections. This drug demonstrates similar activity to vancomycin, ...
Status:
US Approved Rx (2023)
First approved in 2008

Class (Stereo):
CHEMICAL (ABSOLUTE)



Alvimopan (LY246736, ADL 8-2698, trade name Entereg) is a potent, peripherally selective mu-opioid receptor antagonist. Alvimopan was developed by Adolor Corporation (now Cubist Pharmaceuticals) and GlaxoSmithKline for the treatment of postoperative ...
Status:
US Approved Rx (2006)
First approved in 2006

Class (Stereo):
CHEMICAL (ABSOLUTE)



Anidulafungin (brand names Eraxis (in U.S. and Russia) and Ecalta (in Europe)) is a semi-synthetic echinocandin with antifungal activity and it is active in vitro against many Candida, as well as some Aspergillus. Like other echinocandins, anidulafun...
Status:
US Approved Rx (2013)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is indicated for the acute and maintenance treatment of major depressive disorder (MDD), as well as acute management of generalized anxiety disorder. Also used ...
Status:
US Approved Rx (2022)
First approved in 2004

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pemetrexed is a new-generation antifolate, approved for the treatment of mesothelioma and non-small cell lung cancer, currently being evaluated for the treatment of a variety of other solid tumors. Pemetrexed, is a folate analog metabolic inhibitor ...
Status:
US Approved Rx (2003)
First approved in 2003

Class (Stereo):
CHEMICAL (ACHIRAL)



NAMENDA (marketed under the brands Namenda among others) is an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Persistent activation of central nervous system N-methy...
Status:
US Approved Rx (2010)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. The precise mechanism by which atomoxetine produces its therapeutic effects in Attention-Deficit/Hyperactivity Disorder (ADHD) is unknown, but is thought to be re...
Status:
US Approved Rx (2007)
First approved in 1997

Class (Stereo):
CHEMICAL (ACHIRAL)



Raloxifene (marketed as Evista by Eli Lilly and Company) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. Raloxifene binds to estrogen receptors, resulti...
Status:
US Approved Rx (2021)
First approved in 1996

Class (Stereo):
CHEMICAL (ACHIRAL)



Olanzapine is a novel antipsychotic agent marketed by Lilly & Co. It has a pleotrophic pharmacology and affects dopaminergic, serotonergic, muscarinic and adrenergic activities. Olanzapine is used to treat the symptoms of psychotic conditions suc...